Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 26.3.2018 | EN | Official Journal of the European Union | C 112/42 |

---

Action brought on 5 February 2018 — Endoceutics v EUIPO — Merck (FEMIVIA)

(Case T-59/18)

(2018/C 112/53)

Language in which the application was lodged: English

Parties

Applicant: Endoceutics, Inc. (Quebec, Quebec, Canada) (represented by: M. Wahlin, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Merck KGaA (Darmstadt, Germany)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant

Trade mark at issue: EU word mark ‘FEMIVIA’ — Application for registration No 13 148 986

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 27 November 2017 in Case R 280/2017-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the Applicant’s costs both at EUIPO and at the General Court. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation No 2017/1001. |

---

[Top](#document1)